Vol. 276, Issue 6, H2102-H2108, June 1999
End-systolic myocardial stiffness is a load-independent index
of contractility in stage 24 chick embryonic heart
Kimimasa
Tobita and
Bradley B.
Keller
Division of Pediatric Cardiology, Department of Pediatrics,
University of Kentucky, Lexington, Kentucky 40536-0298
 |
ABSTRACT |
Cardiac
morphogenesis and function are interrelated during cardiovascular
development. We evaluated the effects of acute alteration of loading
condition to chick embryonic ventricular contractility using
end-systolic myocardial stiffness based on the incremental elastic
modulus concept. End-systolic stress-strain relations including
geometric factor and end-systolic myocardial stiffness were determined
from the simultaneous measurement of ventricular pressure and chamber
dimension in the following four groups of stage 24 White Leghorn chick
embryos: volume infusion (n = 9), conotruncal occlusion (n = 9), calcium
suffusion (n = 10), and verapamil
suffusion (n = 8). The end-systolic
stress-strain relationship was linear in each embryo. There was no
correlation between end-systolic myocardial stiffness and end-systolic
stress. End-systolic myocardial stiffness increased with calcium
suffusion (P < 0.05 vs. volume infusion). The geometric factor increased after verapamil suffusion (P < 0.05). End-systolic myocardial
stiffness normalized by geometric factor was not changed by alteration
of preload or afterload, increased after calcium suffusion, and
decreased after verapamil administration
(P < 0.05). These results suggest
that normalized end-systolic myocardial stiffness is a load-independent
index of ventricular contractility in the developing embryonic chick ventricle.
chick embryonic ventricle; end-systolic stress-strain relationship
 |
INTRODUCTION |
THE DEVELOPING CARDIOVASCULAR
system can acutely and chronically adapt to changes in preload,
afterload, and contractility (11). Congenital cardiovascular anomalies
occur as the result of abnormal maturation of cardiac function and
altered morphogenesis (2, 5, 7). During the embryonic period of rapid
cardiovascular growth and morphogenesis in avian and mammalian species,
the heart transforms from a straight tube to a looped tube to a
four-chamber heart, and there is dramatic maturation of the ventricular
myocardium (17). Embryonic cardiovascular adaptation occurs at the
tissue and cellular levels; however, there are limits to embryonic
cardiovascular adaptation that result in a normal mature phenotype.
Several experimental models in the chick embryo reproducibly result in
structural anomalies identical to those seen in patients (1, 9, 22).
Many indexes of embryonic cardiovascular function such as ventricular
pressure, cardiac output and arterial impedance are interdependent (4,
12, 13, 30). Despite the size and geometry of the embryonic heart,
ventricular-vascular interactions can be determined using
pressure-volume relations and arterial impedance (12, 30). These
studies suggest that the embryonic cardiovascular system rapidly alters
cardiac output and arterial impedance in response to altered loading
conditions (30). It is less clear, however, whether ventricular
"contractility" changes acutely or chronically because of the
"load dependence" of standard indexes of cardiovascular function
(12, 13).
Relatively "load-independent" measures of ventricular function
include maximum end-systolic elastance (18) and systolic myocardial
stiffness (16). The basic model of time-varying elastance assumes that
arterial load is constant. Previous attempts to analyze embryonic
end-systolic pressure-volume relations (ESPVR) have been complicated by
extreme curvilinearity of these relations because of simultaneous
changes in arterial tone (10, 13, 24). However, acute conotruncal
occlusion isolates the ventricle from the arteries, allowing a new,
accurate assessment of embryonic ventricular function (13).
We investigated ESPVR and maximum systolic stiffness during acute
changes in ventricular preload, afterload, and myofilament activation.
End-systolic myocardial stiffness normalized for changes in geometry
reflected changes in contractility in the embryonic heart.
 |
MATERIALS AND METHODS |
Embryo preparation and developmental staging.
Vertebrate cardiac morphogenesis follows a relatively similar process,
although with different time lines, across a broad range of species
(11). In the present study, we selected the Hamburger-Hamilton stage 24 chick embryo (8), because this developmental stage is representative of
the embryonic heart containing a trabecular myocardium before cardiac
septation (19). The stage 24 chick embryo is comparable to embryonic
day 12.5 in the mouse and to Streeter horizon XV in humans (20).
Fertilized White Leghorn chicken eggs were incubated blunt end up in a
forced-draft incubator to Hamburger-Hamilton stage 24 (4 days) of a
46-stage (21 days) incubation period (8). Each egg was positioned on a
photomacroscope stage under radiant warmers to maintain ambient
temperature between 37 and 38°C. An ~1-cm2 hole in the shell was
made, and the inner shell and extraembryonic membranes were removed to
expose the developing embryo. Embryos that were dysmorphic or exhibited
overt bleeding were excluded from future study.
Hemodynamic preparation.
We simultaneously measured intraventricular pressure and ventricular
dimensions using a custom-integrated physiological and morphometry
workstation. A fluid-filled glass capillary pipette was positioned with
the use of a micromanupulator (Leitz, Wetzlar, Germany) to puncture the
developing right ventricle, and the intraventricular pressure was
measured using a servo-null pressure system (model 900A, World
Precision Instruments, Sarasota, FL). The servo-null pressure is linear
(y = 0.995x
0.23, r = 0.99, SE = 0.11 mmHg) to a standing water column over the range of 0-10 mmHg, and
the rise time of the pressure system is <10 ms (3). Video images were
acquired using a photomacroscope (model M400, Wild Leitz, Rockleigh,
NJ), a video camera (model 70-new viscon tube, Dage-MTI, Michigan City,
IN), a frame-grabber board (LG-3, Scion, Frederick, MD), and a
custom-programmed analog-digital image acquisition system (LabVIEW,
National Instruments, Austin, TX). This custom acquisition system
simultaneously captured video images at 60 Hz and intraventricular
pressure at 600 Hz with an analog-digital board (AT-MIO 16; National
Instruments) for 4 s. The pressure waveform was decimated from 600 to
60 Hz and interpolated with the image data. A 50-µm-division scribed
glass standard was recorded in the plane of each embryo after imaging
for calibration of image analysis software (LabVIEW). Baseline image
and pressure data were recorded in each embryo before experimental interventions.
Ventricular preload alteration.
We obtained ventricular pressure and dimension data during increasing
ventricular preload by rapid volume injection. Rapid volume injection
was performed using a 50-µl graduated syringe (Hamilton, Reno, NV)
and a programmable microsyringe pump (SP210iw, World Precision
Instruments). The syringe was connected by plastic tubing via a
three-way stopcock to a reservoir of warmed, oxygenated Krebs-Henseleit
buffer (KHB) and a 10-µm-tip diameter glass pipette inserted into the
sinus venosus. Pressure and image data were acquired simultaneously
during a single 2-µl-volume injection over 5 s (0.4 µl/s).
Ventricular afterload alteration.
Our previous study of acute, near-complete conotruncal occlusion showed
that embryonic ventricular peak systolic pressure and end-diastolic
volume changed almost simultaneously in response to the near-complete
conotruncal occlusion (13). This rapid preload response to alteration
of afterload in the embryo confounded our attempt to change ventricular
afterload without changing preload. Thus, in the present study, we
altered only afterload without changing preload by gradual conotruncal
occlusion. The conotruncus was occluded using a microforceps mounted on
a micromanupulator. The forceps was closed gradually over 5 s to narrow
the conotruncus until end-diastolic volume visibly increased.
Alteration of contractility.
The immature embryonic ventricular myocyte primarily regulates
intracellular calcium via the sarcolemma (6, 28). We used KHB
containing either 6 mM ionized calcium or 2 mM ionized calcium plus 4 × 10
5 mM verapamil to
increase or decrease myofilament calcium availability, respectively.
These buffer solutions reproducibly alter twitch force in the isolated
embryonic myocardium (B. B. Keller, unpublished data).
Measurement of arterial impedance.
We measured dorsal aortic blood pressure and flow velocity
simultaneously as previously described (30) and then calculated arterial impedance using a three-element windkessel model before and
during the rapid volume injection in the same-stage chick embryos.
Experimental protocols.
We analyzed hemodynamic data in the following four groups of embryos.
In the volume infusion protocol (n = 9), a rapid volume injection was performed. In the conotruncus
occlusion protocol (n = 9), a gradual
conotruncal occlusion was performed. In the calcium suffusion protocol
(n = 10), 10 µl of KHB containing 6 mM ionized calcium was suffused onto the ventricle and a rapid volume
injection was performed 30 s later. In the verapamil suffusion protocol
(n = 8), 10 µl of KHB containing 4 × 10
5 mM verapamil
was suffused onto the ventricle and a rapid volume injection was
performed 30 s later. After the completion of data recording, maximal
ventricular contraction and cavity obliteration were achieved using
topical 2 M sodium chloride administration in each embryo to allow the
calculation of myocardial wall volume (12).
Video image processing.
We planimetered the ventricular epicardial border manually from each
video field and measured epicardial ventricular cross-sectional area
(A) (Fig.
1). Intra- and interobserver error of area
measurement by planimetry is not significant
(P > 0.29 and
P > 0.96, respectively) (12).
Ventricular volume was calculated using a simplified ellipsoidal geometric model. The ellipsoid equation is derived from equations for
A of an ellipsoid,
A =
DL, and the volume (V) of the
ellipsoid of revolution, V = (4
D2L)/3,
where D is the minor semiaxis and
L is the major semiaxis. We measured
epicardial ventricular L and
D at maximum and minimum A in each embryo (Table
1) and assumed a fixed ventricular aspect ratio
(L/D = 4/3) during the entire cardiac cycle; thus V = 0.65A3/2.
Ventricular cavity volume (Vc)
was calculated as total volume (Vt) minus myocardial wall
volume (Vm). Ventricular
internal minor semiaxis dimension
(Di) and wall
thickness (h) were calculated by the
following equations
|
|
|
|
|
|
|
(1)
|
where
Li is the
internal major semiaxis dimension and
Li/Di = 4/3. In addition, the material properties of the embryonic myocardium
are assumed to be constant during acute change of the ventricular
volume (24).

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 1.
Representative video image of embryonic heart at end diastole
(A) and cavity obliteration using
topical 2 M NaCl administration (B)
in 1 embryo. Ventricular epicardial border was planimetered in each
video field and ventricular cross-sectional area was calculated. Arrows
indicate ventricular major and minor axis dimensions. C, conotruncus;
S, sinus venosus; V, ventricle; *, microforceps for gradual conotruncal
occlusion; §, fluid-filled glass capillary pipette inserted into
ventricle to measure ventricular pressure.
|
|
End-systolic myocardial stiffness.
With the use of elasticity theory, an arbitrary state of stress or
strain is expressible as the sum of hydrostatic and deviatric stresses
or strains. For an incompressible elastic material, all strains are
deviatric (because volumes are preserved), and thus the deviatric
stress alone is determined by the strain (27). The hydrostatic stress
is determined from the boundary values of the stress. Thus in an
r,
,
coordinate system, the
total stress components
i may
be expressed in terms of the strain components
i as
|
(2)
|
where
P0 is a uniform hydrostatic
pressure, E is Young's modulus, and
r,
, and
are radial,
circumferential, and meridional coordinates, respectively.
Strain difference
.
Assuming the embryonic ventricle to be a thick-walled ellipsoidal
shell, total strain difference
is defined as the difference of the
circumferential (
) and
radial (
r) strain components
at the equator of the ellipsoid (16). Using the natural strain
definition, the strain difference is expressed as
|
(3)
|
Thus
the total strain difference is calculated by
|
(4)
|
where
Dm,
Lm, and
D0,m are,
respectively, minor semiaxis, major semiaxis, and zero-stress minor
semiaxis midwall diameter at the equator.
Stress difference
.
Stress difference
is defined as the difference of the
circumferential (
) and
radial (
r) stress
components. Note that these stresses are averaged over the entire cross
section at the equator of an ellipsoid (15, 16). Thus the average stress difference
is calculated by
|
(5)
|
where

,a and
r,a are
the average circumferential and radial stresses and P is left
ventricular pressure.
Average systolic myocardial stiffness.
From Eq. 2, the average systolic
myocardial stiffness
(Eav) is
calculated as
|
(6)
|
Note
that Eq. 6 indicates that the
stress-strain relationship is linear (18).
ESPVR based on end-systolic stress-strain relations.
Ventricular midwall volume (Vm)
based on the thick-walled ellipsoidal model is
|
(7)
|
Assuming
that
Lm/Dm = 4/3, then
|
(8)
|
where
k = (
)
.
We can then use Vm and
V0,m to calculate
|
(9)
|
where
V0,m is zero-stress midwall
volume. Thus Eq. 6 is expressed as
|
(10)
|
We
then converted end-systolic stress-strain relations to ESPVR using the
equation
|
(11)
|
where
es,
Pes, and
Ves are end-systolic stress
difference, end-systolic pressure, and end-systolic midwall volume,
respectively. G,
, and
are a
geometric factor and regression coefficients, respectively.
Using Eqs. 10 and 11, ESPVR are expressed as
|
(12)
|
Note
that Eq. 12 indicates that ESPVR are curvilinear.
Determination of end-systolic stress-strain points.
Each end-systolic stress-strain point is defined as the point where the
-to-
ratio reaches a maximum after the onset of systole. We
calculated the end-systolic stress-strain point in the following
iterative manner.
D0,m was first
assumed. End-systolic stress-logarithmic midwall dimension points were
then fit by linear-regression analysis. A new
D0,m was then
obtained by extrapolation to zero stress. This iterative procedure was
continued until the value for
D0,m converged.
Statistical analysis.
Data are presented as means ± SE. Two-way repeated-measures ANOVA
was used to assess the time course of the changes of arterial impedance
during rapid volume injection between each group. The mean values for
each group were analyzed by one-way ANOVA. When an assumption of either
data normality or equal variance was violated, a nonparametric
Kruskal-Wallis test was performed. Individual comparison was performed
by a Duncan's multiple-range test. Statistical significance was
defined by a value of P < 0.05. Linear regression analysis with the minimum least square method was
performed to analyze the end-systolic stress-dimension, stress-strain
relations, and geometric factor. To evaluate linearity, we performed an
F-test in each linear-regression
analysis. All calculations were performed using Statistica (Statsoft,
Tulsa, OK).
 |
RESULTS |
Hemodynamic data.
Table 2 shows hemodynamic data after
intervention in each group. Embryonic heart rate and peak pressure were
similar among all groups (P > 0.50).
End-diastolic volume increased after verapamil suffusion
(P < 0.05 vs. volume infusion).
Table 3 shows arterial impedance after
volume infusion, Ca2+, and
verapamil treatments. Peripheral resistance
(P = 0.38), characteristic impedance
(P = 0.08), and total arterial
compliance (P = 0.22) were unaffected
by these acute interventions.
End-systolic stress-strain relations.
Figure 2 displays end-systolic
stress-dimension and stress-strain relations for one representative
embryo. F-test indicated that these
relations showed no significant departure from linearity. Extrapolation
of these relations yielded
D0,m. Figure
3 and Table 4 show that
F-test demonstrated no significant
departure from linearity in any group and that no statistical
relationship was observed between end-systolic myocardial stiffness and
stress. These results indicate that end-systolic myocardial stiffness is independent of end-systolic stress over a wide range of stresses.


View larger version (37K):
[in this window]
[in a new window]
|
Fig. 2.
A: representative graph of
end-systolic stress-logarithmic midwall dimension relations in 1 embryo. F-test indicates that
end-systolic stress-logarithmic dimension relations are linear.
es, End-systolic stress
difference; Dm,
midwall dimension;
Des, end-systolic
midwall dimension. Extrapolation of relations revealed zero-stress
dimension
(D0,m).
B: representative stress-strain loops
and end-systolic stress-strain relations of 1 embryo. Slope of
end-systolic stress-strain relation is defined as maximum myocardial
stiffness. , End-systolic stress difference; , end-systolic
strain difference.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Representative stress-strain loops and end-systolic stress-strain
relations during altered loading condition and contractility.
End-systolic stress-strain relations are linear in each intervention.
Slope (end-systolic myocardial stiffness) increased only after
Ca2+ suffusion
(P < 0.05 vs. volume infusion).
Infusion, volume infusion; Occlusion, gradual conotruncal occlusion;
Ca2+, suffusion with buffer
containing 6 mM ionized calcium; verapamil, suffusion with buffer
containing 4 × 10 5 mM
verapamil.
|
|
View this table:
[in this window]
[in a new window]
|
Table 4.
Multiple-regression coefficients of end-systolic stress-strain and
end-systolic stiffness-stress relations
|
|
End-systolic myocardial stiffness, G,
and V0,m.
End-systolic myocardial stiffness
(Eav,max)
increased only after Ca2+
suffusion (P < 0.05).
G increased only after verapamil
suffusion (P < 0.05). End-systolic
myocardial stiffness normalized by G (Eav,max/G)
increased after Ca2+ suffusion and
decreased after verapamil suffusion (P < 0.05). V0,m increased after
verapamil suffusion (P < 0.05, Table
5). Figure 4
shows that pressure-volume relations based on the stress-strain relationship are curvilinear and that
Eav,max/G
is the slope of these relations.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
Representative pressure-volume loops and end-systolic pressure-volume
relations based on maximum myocardial stiffness concept during altered
loading condition and contractility. End-systolic pressure-volume
relations are curvilinear. Slope
(Eav/G) was
relatively insensitive to alterations of preload or afterload,
increased after Ca2+ suffusion,
and decreased after verapamil suffusion
(P < 0.05 vs. volume infusion).
Abbreviations are as in Fig. 3.
|
|
 |
DISCUSSION |
End-systolic stress-strain relationship: systolic myocardial
stiffness concept.
In the original theory of maximum ventricular elastance, the ESPVR is
linear and the maximum ventricular elastance is sensitive to the
ventricular contractility and is independent of loading conditions
(18). However, animal and clinical studies revealed curvilinearity of
ESPVR, resulting in a revised curvilinear model with contractility and
a geometric factor (10, 16, 21, 26). Taber et al. (24, 29) modeled
curvilinear ESPVR in chick embryonic ventricle theoretically using the
thick-walled cylindrical tube model and correlated experimental wall
strains and ESPVR with a pseudostrain-energy density function of the
myocardium. According to the model of Mirsky et al. (16), ventricular
end-systolic stress-strain relations are linear and the slope of the
relationship, Eav,max, is
independent of ventricular load and sensitive to altered ventricular
contractility. The linear end-systolic stress-strain relationship
implies a curvilinear ESPVR. The present study showed that the
end-systolic stress-strain relations in chick embryonic ventricle were
linear and that end-systolic myocardial stiffness was independent of
end-systolic stress. These relations were not changed by the
alterations of loading condition. The results of the present study were
similar to those in the mature left ventricle and indicate that the
systolic myocardial stiffness concept is useful to assess the
contractility of the developing myocardium.
End-systolic myocardial stiffness, geometric factor, and normalized
end-systolic myocardial stiffness.
From Eq. 12, ESPVR is expressed as
Pes = (41/72) · (Eav,max/G) · ln(Ves/V0,m).
Note that the slope of the curve is determined by
Eav,max/G.
In the mature left ventricle, changes of
Eav,max directly
reflect the alteration of contractility because
G is close to unity during altered
load (16). In the present study, G of
the verapamil suffusion group was significantly higher than that of
other groups.
Simply stated, G was described by
Mirsky et al. (16) as a conversion factor between stress-strain
relations and pressure-volume relations. We calculated this factor from
each embryonic ventricle using the method of Mirsky et al. This factor
is a constant of each heart, and it represents the effect of the
ventricular dimension-wall thickness relation to wall stress. In the
present study, we assumed the embryonic ventricle as a simplified
ellipsoid, and the
L-to-D ratio was not changed in any group (Table 1). Previous study of
surfacial epicardial strain in stage 24 chick embryo showed that the
magnitudes of circumferential and longitudinal strains were similar to
each other, implying that the embryonic ventricle contracts
isotropically in both directions at this stage (25). Increased
G in the verapamil group indicates dilatation of the ventricular cavity and thinning of the ventricular wall. Thus, in
embryonic ventricle, end-systolic myocardial stiffness normalized by a
geometric factor,
Eav,max/G,
should be used to evaluate alterations in ventricular contractility.
Eav,max/G
was not changed in preload or afterload alterations, increased after
Ca2+ suffusion, and decreased
after verapamil suffusion. In this stage of embryonic ventricle, the
myocytes have a limited calcium reserve and poorly developed
sarcoplasmic reticulum and T-tubule system (6, 28). Extracellular
calcium directly regulates the force generation of contractile proteins
(28). Thus,
Eav,max/G
is load independent and reflects changes in ventricular contractility.
Ventricular zero-stress volume.
Ventricular zero stress volume increased after verapamil suffusion.
Ventricular dimension and geometry at the zero-stress point depend on
residual strain. Previous data on residual strain in the chick
embryonic ventricle show that residual strain changes dramatically at
the onset of trabeculation, suggesting that residual strain is
sensitive to changes in ventricular structure (23). From this point of
view, even in the same stage of the embryo, residual strain may be
changed by conditions that alter ventricular geometry. Thus further
experiments are needed to directly evaluate myocardial properties,
including material properties and residual strain during changes in
Ca2+ flux.
Assumptions and limitations.
There are several assumptions and limitations to the present study.
First, the embryonic ventricle is assumed to be a thick-walled ellipsoidal shell with a fixed ratio of semiminor and semimajor axis
diameter during systole. The actual ventricular shape in chick
embryonic ventricle at this stage is more complex than a simple
ellipsoidal shell. Thus our method of calculation of ventricular cavity
volume and wall thickness may not accurately assess absolute volume and
wall thickness changes during the cardiac cycle. In addition, this
analysis is also influenced by changes in myocardial trabeculation.
However, at present, there are no more accurate methods to assess
absolute ventricular volumes and wall thickness in the embryonic heart.
Second, the calculation of embryonic myocardial stress and strain
depends on the model formulations. Strain-time curves and peak strains
in the present study were similar to previous data in the embryonic
heart (25). To calculate the embryonic ventricular wall stress, we
assumed that the embryonic myocardium is a freely deforming body
composed of an isotropic, homogeneous, and incompressible elastic
material. Several models can be used to quantify wall stress; however,
it is difficult to compare our results of end-systolic wall stress with
those obtained for the mature left ventricle. Yang et al. (29) measured
epicardial Lagrangian strain in the stage 21 chick embryonic ventricle
and computed circumferential wall stress distribution based on a
thick-walled pseudoporoelastic cylindrical model. The end-systolic
transmural stress gradient of chick embryonic ventricle was proposed to
be smaller than that of mature left ventricle because of the
strain-softening constitutive relations of embryonic myocardium.
However, limited experimental data is available to support their
assumptions regarding embryonic myocardial material properties (14).
Finally, the theoretical model of systolic stiffness concept assumes
that stress is a function of strain alone. Viscous and inertial effects
are excluded. Although these effects do not significantly influence
end-systolic stiffness in the mature left ventricle, the embryonic
myocardium differs markedly in ultrastructure, with a small volume
fraction of organized extracellular matrix and less anisotropy (25). In
addition, recent data of the passive myocardial stress-strain relations
in stage 16 and stage 18 embryos show that the hysteresis loops are
larger than mature myocardium, indicating different viscoelastic
properties (14). Further study is needed to evaluate how changes in
material properties influence embryonic ventricular end-systolic
stress-strain relations and systolic myocardial stiffness during
maturation of the embryonic myocardium.
The present study is the first evaluation of ventricular contractility
using end-systolic stress-strain relations and maximum systolic
myocardial stiffness in the embryonic ventricle. Our results showed
that the end-systolic myocardial stiffness normalized by a geometric
factor is a load-independent index of the embryonic ventricular contractility.
 |
ACKNOWLEDGEMENTS |
The authors acknowledge Dr. Masaaki Yoshigi for programming the
analog-digital image acquisition system.
 |
FOOTNOTES |
This research was supported by National Institutes of Health
Specialized Center of Research in Pediatric Cardiovascular Diseases P50-HL-51498 (B. B. Keller).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests: K. Tobita, Div. of Pediatric Cardiology,
Univ. of Kentucky, 800 Rose St., Rm. MN472, Lexington, KY 40536-0298 (E-mail: ktobi0{at}pop.uky.edu).
Received 5 October 1998; accepted in final form 12 February 1999.
 |
REFERENCES |
1.
Broekhuizen, M. L.,
H. G. Bouman,
F. Mast,
P. G. Mulder,
A. C. Gittenberger-de Groot,
and
J. W. Wladimiroff.
Hemodynamic changes in HH stage 34 chick embryos after treatment with all-trans-retinoic acid.
Pediatr. Res.
38:
342-348,
1995[Medline].
2.
Clark, E. B.
Cardiac embryology: its relevance to congenital disease.
Am. J. Dis. Child.
140:
41-44,
1986[Medline].
3.
Clark, E. B.,
and
N. Hu.
Developmental hemodynamic changes in the chick embryo from stages 18 to 27.
Circ. Res.
51:
810-815,
1982[Abstract/Free Full Text].
4.
Clark, E. B.,
N. Hu,
J. L. Dummett,
G. K. Vandekieft,
C. Olsen,
and
R. Tomasek.
Ventricular function and morphology in chick embryo from stage 18 to 29.
Am. J. Physiol.
250 (Heart Circ. Physiol. 19):
H407-H413,
1986[Abstract/Free Full Text].
5.
Clark, E. B.,
and
A. Takao.
Overview: a focus for research in cardiovascular development.
In: Developmental Cardiology: Morphogenesis and Function, edited by E. B. Clark,
and A. Takao. New York: Futura, 1990, p. 3-12.
6.
Davis, M. P.,
R. H. An,
P. Doevendans,
S. Kubalak,
K. R. Chien,
and
R. S. Kass.
Developmental changes in ionic channel activity in the embryonic murine heart.
Circ. Res.
78:
15-25,
1996[Abstract/Free Full Text].
7.
Gittenberger-de Groot, A. C.,
M. M. Bartelings,
and
R. E. Poelmann.
Normal and abnormal morphogenesis of the outflow tract.
In: Developmental Mechanisms of Heart Disease, edited by E. B. Clark,
R. R. Markwald,
and A. Takao. New York: Futura, 1995, p. 249-253.
8.
Hamburger, V.,
and
H. L. Hamilton.
A series of normal stages in the development of the chick embryo.
J. Morphol.
88:
49-92,
1951.
9.
Hogers, B.,
M. C. DeRuiter,
A. C. Gittenberger-de Groot,
and
R. E. Poelmann.
Unilateral vitelline vein ligation alters intracardiac blood flow patterns and morphogenesis in the chick embryo.
Circ. Res.
80:
473-481,
1997[Abstract/Free Full Text].
10.
Kass, D. A.,
R. Beyar,
E. Lankford,
M. Heard,
W. L. Maughan,
and
K. Sagawa.
Influence of contractile state on curvilinearity of in situ end-systolic pressure-volume relations.
Circulation
79:
167-178,
1989[Abstract/Free Full Text].
11.
Keller, B. B.
Embryonic cardiovascular function, coupling, and maturation: a species view.
In: Development of Cardiovascular Systems, edited by W. W. Burggren,
and B. B. Keller. Cambridge, UK: Cambridge Univ. Press, 1998, p. 65-87.
12.
Keller, B. B.,
J. P. Tinney,
and
N. Hu.
Embryonic ventricular diastolic and systolic pressure-volume relations.
Cardiol. Young.
4:
19-27,
1994.
13.
Keller, B. B.,
M. Yoshigi,
and
J. P. Tinney.
Ventricular-vascular uncoupling by acute conotruncal occlusion in the stage 21 chick embryo.
Am. J. Physiol.
273 (Heart Circ. Physiol. 42):
H2861-H2866,
1997.
14.
Miller, C. E.,
M. A. Vanni,
L. A. Taber,
and
B. B. Keller.
Passive stress-strain measurements in the stage 16 and stage 18 embryonic chick heart.
J. Bio. Eng.
119:
1-7,
1997.
15.
Mirsky, I. Elastic properties of the myocardium: a
quantitative approach with physiological and clinical applications.
In: Handbook of Physiology.
The Cardiovascular System. The Heart.
Bethesda, MD: Am. Physiol. Soc. 1979, sect. 2, vol. I, chapt. 14, p.
497-531.
16.
Mirsky, I.,
T. Tajimi,
and
K. L. Peterson.
The development of the entire end-systolic pressure-volume and ejection fraction-afterload relations: a new concept of systolic myocardial stiffness.
Circulation
76 (2):
343-356,
1987[Abstract/Free Full Text].
17.
Pexieder, T.,
and
P. Janecek.
Organogenesis of the human embryonic and early fetal heart as studied by microdissection and SEM.
In: Congenital Heart Disease: Causes and Processes, edited by A. Takao,
and I. Nora. New York: Futura, 1984, p. 401-421.
18.
Sagawa, K.,
W. L. Maughan,
H. Suga,
and
K. Sunagawa.
Physiologic determinations of pressure-volume relations.
In: Cardiac Contraction and the Pressure-Volume Relationship. New York: Oxford Univ. Press, 1988, p. 110-172.
19.
Sedmera, D.,
T. Pexieder,
N. Hu,
and
E. B. Clark.
Developmental changes in the myocardial architecture of the chick.
Anat. Rec.
248:
421-432,
1997[Medline].
20.
Sissman, N. J.
Developmental landmarks in cardiac morphogenesis: comparative chronology.
Am. J. Cardiol.
25:
141-148,
1970[Medline].
21.
Suga, H.,
O. Yamada,
Y. Goto,
and
Y. Igarashi.
Peak isovolumic pressure-volume relation of puppy left ventricle.
Am. J. Physiol.
250 (Heart Circ. Physiol. 19):
H167-H172,
1986.
22.
Sweeney, L.
Morphometric Analysis of an Experimental Model of Left Heart Hypoplasia in the Chick. (PhD thesis). Omaha, NE: Univ. of Nebraska Medical Center, 1981.
23.
Taber, L. A.,
N. Hu,
T. Pexieder,
E. B. Clark,
and
B. B. Keller.
Residual strain in the ventricle of the stage 16-24 chick embryo.
Circ. Res.
72:
455-462,
1993[Abstract/Free Full Text].
24.
Taber, L. A.,
B. B. Keller,
and
E. B. Clark.
Cardiac mechanism in the stage 16 chick embryo.
J. Biomech. Eng.
114:
427-434,
1992[Medline].
25.
Taber, L. A.,
H. Sun,
E. B. Clark,
and
B. B. Keller.
Epicardial strains in embryonic chick ventricle at stage 16 through 24.
Circ. Res.
75:
896-903,
1994[Abstract/Free Full Text].
26.
Tachibana, H.,
M. Takaki,
S. Lee,
H. Ito,
H. Yamaguchi,
and
H. Suga.
New mechanoenergetic evaluation of left ventricular contractility in in situ rat hearts.
Am. J. Physiol.
272 (Heart Circ. Physiol. 41):
H2671-H2678,
1997[Abstract/Free Full Text].
27.
Timoshenko, S.,
and
J. N. Goodier.
Theory of Elasticity. New York: McGraw-Hill, 1951, p. 1-10.
28.
Vetter, R.,
and
H. Will.
Sarcolemmal Na-Ca exchange and sarcoplasmic reticulum calcium uptake in developing chick heart.
J. Mol. Cell. Cardiol.
18:
1267-1275,
1986[Medline].
29.
Yang, M.,
L. A. Taber,
and
E. B. Clark.
A nonlinear poroelastic model for the trabecular embryonic heart.
J. Biomech. Eng.
116:
213-223,
1994[Medline].
30.
Yoshigi, M.,
N. Hu,
and
B. B. Keller.
Dorsal aortic impedance in stage 24 chick embryo following acute changes in circulating blood volume.
Am. J. Physiol.
270 (Heart Circ. Physiol. 39):
H1597-H1606,
1996[Abstract/Free Full Text].
Am J Physiol Heart Circ Physiol 276(6):H2102-H2108
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society